BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23137997)

  • 1. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
    Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
    Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
    Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
    Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
    Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
    J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients.
    Damude S; Hoekstra HJ; Bastiaannet E; Muller Kobold AC; Kruijff S; Wevers KP
    Eur J Surg Oncol; 2016 Apr; 42(4):545-51. PubMed ID: 26831006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes.
    Murali R; Desilva C; Thompson JF; Scolyer RA
    J Clin Oncol; 2010 Oct; 28(29):4441-9. PubMed ID: 20823419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma.
    Damude S; Wevers KP; Murali R; Kruijff S; Hoekstra HJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Sep; 43(9):1753-1759. PubMed ID: 28797756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients.
    Cadili A; Dabbs K; Scolyer RA; Brown PT; Thompson JF
    J Am Coll Surg; 2010 Oct; 211(4):522-5. PubMed ID: 20729103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model.
    Wiener M; Acland KM; Shaw HM; Soong SJ; Lin HY; Chen DT; Scolyer RA; Winstanley JB; Thompson JF
    Ann Surg Oncol; 2010 Aug; 17(8):1995-2005. PubMed ID: 20490699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
    J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
    Nagaraja V; Eslick GD
    Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic area ratio can help predict nonsentinel node positivity in melanoma patients.
    Bertolli E; Macedo MP; Pinto CA; Damascena AS; Molina AS; Duprat Neto JP
    Melanoma Res; 2016 Feb; 26(1):42-5. PubMed ID: 26397049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A; Ghazarian DM; McCready DR; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of nonsentinel lymph node metastasis in malignant melanoma.
    Cadili A; Smylie M; Danyluk J; Dabbs K
    J Surg Res; 2009 Jun; 154(2):324-9. PubMed ID: 19101696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
    Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
    Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
    van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
    Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
    van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
    Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
    Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.